Inhibitors of lipolysis: potency and mode of action of  - and  -adrenolytics, methoxamine derivatives, prostaglandin E 1  and phenylisopropyl adenosine.
D000241:Adenosine / Q000494:pharmacology*; D000273:Adipose Tissue / Q000378:metabolism*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D004822:Epididymis / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008297:Male; D008729:Methoxamine / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011453:Prostaglandins; D013565:Sympatholytics; D008729:Methoxamine; D000241:Adenosine